| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M |
| P698 | PubMed publication ID | 10738240 |
| P50 | author | Kai Ge | Q39756885 |
| P2093 | author name string | D Wilson | |
| G C Prendergast | |||
| P Nelson | |||
| N C Mao | |||
| S B Malkowicz | |||
| D Sakamuro | |||
| J Tomaszewski | |||
| J Duhadaway | |||
| F Minhas | |||
| R Buccafusca | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate carcinoma | Q18553829 |
| heterozygosity | Q124059385 | ||
| P304 | page(s) | 155-161 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma | |
| P478 | volume | 86 |
| Q37225714 | A phase I study of indoximod in patients with advanced malignancies |
| Q38192904 | Amphiphysin 2 (BIN1) in physiology and diseases |
| Q35850187 | Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry |
| Q33870256 | BAR the door: cancer suppression by amphiphysin-like genes |
| Q52976582 | BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma. |
| Q30157183 | Bin1 SRC homology 3 domain acts as a scaffold for myofiber sarcomere assembly |
| Q22254645 | Bin2, a functionally nonredundant member of the BAR adaptor gene family |
| Q34461438 | Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation. |
| Q35973279 | Characterization of bridging integrator 1 (BIN1) as a potential tumor suppressor and prognostic marker in hepatocellular carcinoma |
| Q39164084 | Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer |
| Q42196063 | Curvature sorting of peripheral proteins on solid-supported wavy membranes |
| Q30410002 | Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy |
| Q38911110 | Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. |
| Q24812646 | Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms |
| Q34291962 | High-grade prostatic intraepithelial neoplasia |
| Q84303355 | High-grade prostatic intraepithelial neoplasia |
| Q24290988 | Human BIN3 complements the F-actin localization defects caused by loss of Hob3p, the fission yeast homolog of Rvs161p |
| Q35228303 | Identification of a novel effector domain of BIN1 for cancer suppression |
| Q34758085 | Immune escape as a fundamental trait of cancer: focus on IDO. |
| Q34394487 | Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. |
| Q37492248 | Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? |
| Q38850971 | Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia |
| Q40137519 | Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancer |
| Q40271517 | Myc confers androgen-independent prostate cancer cell growth |
| Q43267301 | Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma |
| Q34924205 | Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation |
| Q40710021 | Regulation of caveolin-1 expression and secretion by a protein kinase cepsilon signaling pathway in human prostate cancer cells |
| Q39821354 | The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage |
| Q73078887 | The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program |
| Q34555987 | The myc oncogene: MarvelouslY Complex |
| Q44467311 | Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1. |
| Q42053910 | Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding |
| Q27006866 | Trial watch: IDO inhibitors in cancer therapy |
| Q78891781 | hob1+, the fission yeast homolog of Bin1, is dispensable for endocytosis or actin organization, but required for the response to starvation or genotoxic stress |
Search more.